Rhenman & Partners Asset Management Ab Cytokinetics Inc Transaction History

Rhenman & Partners Asset Management Ab

$766 Million
Q2 2025

A detailed history of Rhenman & Partners Asset Management Ab transactions in Cytokinetics Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 104,250 shares of CYTK stock, worth $6.22 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

104,250

Previous 104,250 -0.0%

Holding current value

$6.22 Million

Previous $4.19 Million 17.78%

% of portfolio

0.45%

Previous 0.5%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$40.19 - $51.12 $1.81 Million - $2.3 Million	-45,000 Reduced 30.15%	104,250 $4.19 Million
Q4 2024 Feb 13, 2025	SELL	$46.36 - $58.62 $1.45 Million - $1.83 Million	-31,250 Reduced 17.31%	149,250 $7.02 Million
Q3 2024 Nov 13, 2024	SELL	$51.22 - $60.16 $871,508 - $1.02 Million	-17,015 Reduced 8.61%	180,500 $9.53 Million
Q1 2024 May 14, 2024	BUY	$63.75 - $108.06 $3.03 Million - $5.14 Million	47,603 Added 31.75%	197,515 $13.8 Million
Q4 2023 Feb 13, 2024	SELL	$26.88 - $83.49 $1.35 Million - $4.18 Million	-50,088 Reduced 25.04%	149,912 $12.5 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $5.04 Million - $6.26 Million	171,000 Added 589.66%	200,000 $5.89 Million
Q3 2023 Nov 09, 2023	SELL	$29.46 - $36.61 $5.04 Million - $6.26 Million	-171,000 Reduced 85.5%	29,000 $854,000
Q2 2023 Aug 11, 2023	SELL	$32.62 - $40.75 $163,100 - $203,750	-5,000 Reduced 2.44%	200,000 $6.52 Million
Q1 2023 May 11, 2023	SELL	$33.36 - $45.71 $377,701 - $517,528	-11,322 Reduced 5.23%	205,000 $7.21 Million
Q4 2022 Feb 13, 2023	BUY	$35.77 - $51.11 $226,137 - $323,117	6,322 Added 3.01%	216,322 $9.91 Million
Q3 2022 Nov 14, 2022	SELL	$38.54 - $54.52 $770,800 - $1.09 Million	-20,000 Reduced 8.7%	210,000 $9.17 Million
Q2 2022 Aug 12, 2022	SELL	$33.93 - $48.92 $2.21 Million - $3.18 Million	-65,000 Reduced 22.03%	230,000 $9.04 Million
Q1 2022 May 13, 2022	BUY	$29.74 - $46.0 $4.31 Million - $6.67 Million	145,000 Added 96.67%	295,000 $10.9 Million
Q4 2021 Feb 11, 2022	BUY	$34.35 - $46.38 $5.15 Million - $6.96 Million	150,000 New	150,000 $6.84 Million

Others Institutions Holding CYTK

# of Institutions

389

Shares Held

129M

Call Options Held

3.62M

Put Options Held

1.14M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $5.61B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Cytokinetics Inc Transaction History